Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Recent Toray and Xenon patents disclose novel analgesic agents

Oct. 8, 2008

DSMB recommends continuation of BioMS Medical's MAESTRO-03 trial of dirucotide in MS

Oct. 7, 2008

deCODE files IND for DG-071 for Alzheimer's disease and other cognitive disorders

Oct. 7, 2008

TorreyPines reports successful end-of-phase II meeting with FDA for tezampanel

Oct. 6, 2008

Recent GSK patent describes new analgesic agents

Oct. 6, 2008

Galectin-3 as potential therapeutic target in post-ischemic functional recovery

Oct. 6, 2008

Merck & Co. identifies a novel bradykinin B1 antagonist

Oct. 3, 2008

Phase II/III study results reported for Arocyte for injection in Japan

Oct. 3, 2008

Pharmaleads advances its lead pain compound, PL-37, into phase I trials

Oct. 3, 2008

Orexigen starts phase IIa OREX-003 trial in antipsychotic-associated weight gain

Oct. 3, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...